SKM-1 Cells
CAD$690.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The SKM-1 cell line is a human leukemia model established from the peripheral blood of a patient with acute monoblastic leukemia that developed from myelodysplastic syndrome (MDS). These cells exhibit immature morphological features, such as a high nucleus-to-cytoplasm ratio and fine azurophilic granules, making them an excellent model for studying the molecular and cellular mechanisms of leukemia, particularly the transition from MDS to acute myeloid leukemia (AML). Genetic analysis of SKM-1 has revealed important chromosomal abnormalities, including del(9)(q13;q22) and der(17)t(17:?)(p13:?); the latter alteration involves the p53 gene, which is overexpressed and harbors mutations in this cell line. These findings highlight the role of p53 in clonal evolution and progression of myeloid malignancies. SKM-1 cells are also characterized by their expression of myelomonocytic markers, including CD4, CD13, and CD33, as well as their positivity for butyrate esterase activity, which aligns with their monoblastic lineage. This cell line is widely used in research on leukemogenesis, drug resistance, and the molecular pathways underlying leukemia. For instance, SKM-1 provides a platform for exploring the impacts of p53 dysfunction and other genetic lesions on cell proliferation and therapeutic response. It also serves as a model for investigating novel therapeutic strategies for myelodysplastic syndromes and secondary AML. |
|---|---|
| Organism | Human |
| Tissue | Peripheral blood |
| Disease | acute myleoid leukemia |
| Synonyms | SKM1 |
Characteristics
| Age | 76 years |
|---|---|
| Gender | Male |
| Ethnicity | Japanese |
| Morphology | Round cells |
| Growth properties | Suspension |
Regulatory Data
| Citation | SKM-1 (Cytion catalog number 305627) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_0098 |
Biomolecular Data
| Antigen expression | CD3 -, CD4 (+), CD13 +, CD14 -, CD15 +, CD19 -, CD33 +, HLA-DR +; |
|---|---|
| Viruses | EBV -, HBV -, HCV -, HIV-1 -, HIV-2 -, HTLV-1/2 -, MLV -, SMRV - |
| Mutational profile | Mutation: ASXL1, Simple, p.Tyr591Ter (c.1773C>A), Homozygous; Mutation: BCORL1, Simple, c.4619-1G>A, Homozygous, Splice acceptor Mutation; Mutation: EZH2, Simple, p.Tyr646Cys (c.1937A>G), Heterozygous; Mutation: KRAS, Simple, p.Lys117Asn (c.351A>C), Homozygous; Mutation: TP53, Simple, p.Arg248Gln (c.743G>A), Homozygous |
Handling
| Culture Medium | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Supplements | Supplement the medium with 15% FBS |
| Dissociation Reagent | None |
| Doubling time | 48 hours |
| Seeding density | 0.3 to 1 x 106 cells/ml |
| Fluid renewal | 2 to 3 times per week |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305627-060226 | Certificate of Analysis | 05. Mar. 2026 | 305627 |
-
Related products
Related products
SK-BR-3 CellsOrganism Human Tissue Breast, mammary gland Disease Invasive ductal carcinoma CAD$545.10*